$22.94
2.76% yesterday
Nasdaq, May 19, 10:00 pm CET
ISIN
US09062W2044
Symbol
BLFS

BioLife Solutions, Inc. Stock price

$22.94
+1.79 8.46% 1M
+0.50 2.23% 6M
-3.02 11.63% YTD
+1.11 5.08% 1Y
+10.85 89.74% 3Y
+6.47 39.28% 5Y
+21.04 1,107.37% 10Y
Nasdaq, Closing price Mon, May 19 2025
-0.65 2.76%
ISIN
US09062W2044
Symbol
BLFS
Sector

Key metrics

Market capitalization $1.09b
Enterprise Value $1.03b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 88.82
EV/Sales (TTM) EV/Sales 9.75
P/S ratio (TTM) P/S ratio 10.34
P/B ratio (TTM) P/B ratio 3.09
Revenue growth (TTM) Revenue growth -23.12%
Revenue (TTM) Revenue $105.55m
EBIT (operating result TTM) EBIT $-7.68m
Free Cash Flow (TTM) Free Cash Flow $11.59m
Cash position $88.58m
EPS (TTM) EPS $-0.04
P/E forward negative
P/S forward 11.16
EV/Sales forward 10.53
Short interest 12.25%
Show more

Is BioLife Solutions, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

BioLife Solutions, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a BioLife Solutions, Inc. forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a BioLife Solutions, Inc. forecast:

Buy
100%

Financial data from BioLife Solutions, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
106 106
23% 23%
100%
- Direct Costs 48 48
51% 51%
45%
58 58
43% 43%
55%
- Selling and Administrative Expenses 50 50
24% 24%
47%
- Research and Development Expense 8.55 8.55
53% 53%
8%
-0.36 -0.36
99% 99%
0%
- Depreciation and Amortization 7.32 7.32
36% 36%
7%
EBIT (Operating Income) EBIT -7.68 -7.68
86% 86%
-7%
Net Profit -1.52 -1.52
98% 98%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about BioLife Solutions, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioLife Solutions, Inc. Stock News

Neutral
PRNewsWire
6 days ago
BOTHELL, Wash. , May 14, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the company will be participating in the following investor conferences: 22nd Annual Craig-Hallum Institutional Investor Conference May 28, 2025 Minneapolis, MN at the Renaissan...
Neutral
Seeking Alpha
11 days ago
BioLife Solutions, Inc. (NASDAQ:BLFS ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Troy Wichterman - Chief Financial Officer Roderick de Greef - Chairman and Chief Executive Officer Conference Call Participants Matthew Stanton - Jefferies Paul Knight - KeyBanc Chad Wiatrowski - TD Cowen Thomas Flaten - Lake Street Matthew Hewitt - Craig-Hallum Capital Group Carl...
Neutral
PRNewsWire
12 days ago
BOTHELL, Wash. , May 8, 2025 /PRNewswire/ -- BioLife Solutions, Inc.  (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, is announcing corrected call-in numbers for their Earnings Call this afternoon at 4:30pm ET.
More BioLife Solutions, Inc. News

Company Profile

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Head office United States
CEO Roderick Greef
Employees 159
Founded 1987
Website www.biolifesolutions.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today